Bupropion Hydrochloride
- Product NDC
- 71335-0502
- 11-digit product format
- 713350502
- Labeler code
- 71335
- Product ID
- 71335-0502_965030ad-13a2-4d23-9256-78bca2fea1a1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075932
- Marketing category
- ANDA
- Marketing start
- 2005-06-22
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0502-1 | 71335050201 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0502-1) | 2016-04-01 | 0000-00-00 | No | No | Current |
| 71335-0502-2 | 71335050202 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0502-2) | 2016-04-01 | 0000-00-00 | No | No | Current |
| 71335-0502-3 | 71335050203 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0502-3) | 2016-04-01 | 0000-00-00 | No | No | Current |
| 71335-0502-4 | 71335050204 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0502-4) | 2016-04-01 | 0000-00-00 | No | No | Current |
| 71335-0502-5 | 71335050205 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0502-5) | 2016-04-01 | 0000-00-00 | No | No | Current |
| 71335-0502-6 | 71335050206 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0502-6) | 2016-04-01 | 0000-00-00 | No | No | Current |